JPM Thematics - Genetic Therapies C Fonds
74,31
CHF
+0,22
CHF
+0,30
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,68% |
| Wuxi AppTec Co Ltd | CNE100003F19 | 3,54% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,52% |
| CRISPR Therapeutics AG | CH0334081137 | 3,31% |
| Gilead Sciences Inc | US3755581036 | 3,07% |
| PTC Therapeutics Inc | US69366J2006 | 3,07% |
| Novartis AG Registered Shares | CH0012005267 | 2,99% |
| Amgen Inc | US0311621009 | 2,94% |
| Astellas Pharma Inc | JP3942400007 | 2,87% |
| Bio-Techne Corp | US09073M1045 | 2,70% |
| Sonstige | 68,32% |